SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Centerbridge Partners, L.P.

CIK 0001484836 · 375 PARK AVENUE, 11TH FLOOR, NEW YORK, NY, 10152 · 212 672 5000

Reported Value
$550M
Q3 2019
Positions
22
Filings on Record
33
2019–present window
Filed
Nov 14, 2019
original filing

Summary

Centerbridge Partners, L.P. reported $550M in U.S.-listed holdings across 22 positions for Q3 2019.

The portfolio is heavily concentrated: HGV alone accounts for 23.8% of reported value.

Compared with Q2 2019, the fund opened 2 new positions and exited 1.

Portfolio Metrics

Turnover
+6.3%
vs prior filed quarter
Largest Position
+23.8%
Hilton Grand Vacations
New / Exited
2 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $982MQ4 ’18Q1 ’19: $729MQ2 ’19: $815MQ3 ’19: $550MQ4 ’19: $618MQ4 ’19Q1 ’20: $412MQ2 ’20: $468MQ3 ’20: $894MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $856MQ4 ’21: $1.8BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.1BQ3 ’22: $875MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.0BQ2 ’23: $642MQ3 ’23: $467MQ4 ’23: $604MQ4 ’23Q1 ’24: $623MQ2 ’24: $505MQ3 ’24: $478MQ4 ’24: $468MQ4 ’24Q1 ’25: $510MQ2 ’25: $434MQ3 ’25: $101MQ4 ’25: $59MQ4 ’25Q1 ’26: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 83.6%US DOMESTIC: 7.9%Other: 6.0%ADR: 2.5%
  • Common Stock · 83.6% · $460M
  • US DOMESTIC · 7.9% · $44M
  • Other · 6.0% · $33M
  • ADR · 2.5% · $14M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TEVATEVA PHARMACEUTICAL INDS LTDNEW+1.81M1.81M+$12M$12M
IRSA INVERSIONES Y REP S ANEW+256.2K256.2K+$1M$1M
SGITEMPUR SEALY INTL INCSOLD OUT−1.81M0−$133M$0
ENSCO JERSEY FIN LTDADDED+22.30M64.56M+$11M$44M
SEADRILL LTDTRIMMED−2.70M4.04M−$20M$8M
INTELSAT S AADDED+213.9K1.07M+$8M$24M
PCGPG&E CORPTRIMMED−797.4K8.83M−$132M$88M
AMERICAN RENAL ASSOCIATES HOHELD+017.62M−$20M$111M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

9 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1HGVHILTON GRAND VACATIONS INChistory →COM23.84%$131M4.10M
2AMERICAN RENAL ASSOCIATES HOCOM20.23%$111M17.62M
3GNKGENCO SHIPPING & TRADING LTDhistory →SHS17.53%$96M10.49M
4PCGPG&E CORPhistory →COM16.04%$88M8.83M
5ENSCO JERSEY FIN LTDNOTE 3.000% 1/37.92%$44M64.56M
6INTELSAT S ACOM4.44%$24M1.07M
7FOCUS FINL PARTNERS INCCOM CL A3.90%$21M901.8K
8SEADRILL LTDCOM1.54%$8M4.04M
9IRSA INVERSIONES Y REP S AGLOBL DEP RCPT0.24%$1M256.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$61M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$59M2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$101M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$434M9Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$510M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$468M13Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$478M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$505M17Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$623M20May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$604M20Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$467M25Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$642M27Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.0B29May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B34Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$875M62Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B67Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.6B71May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.8B111Feb 17, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$856M108Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B124Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B109May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.2B36Feb 23, 2021RESTATEMENTchanges · EDGAR ↗
Q3 2020$894M23Nov 17, 202013F-HRchanges · EDGAR ↗
Q2 2020$468M33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$412M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$618M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$550M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$815M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$729M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$982M37Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 8 additional managers.

  • Centerbridge Credit Advisors, L.L.C.028-13862
  • Centerbridge Partners Holdings, LLC028-13861
  • Aronson Jeffrey028-13858
  • Gallogly Mark T028-13857
  • Centerbridge Special Credit Advisors, L.L.C.028-14395
  • Centerbridge Advisors, LLC028-15424
  • Centerbridge Special Credit Advisors II, L.L.C028-16779
  • Centerbridge Special Credit Advisors III, L.L.C.028-19382

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.